Moderna is navigating a post-COVID transition, shifting focus to a diversified vaccine and therapeutics pipeline amid weak demand. Read more on MRNA stock here.
Donald Trump said the United States would hit Iran “hard” again as U.S. officials framed new strikes as a response to Iranian ...